Thomas C Liu
Overview
Explore the profile of Thomas C Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu T, Amorosino M, Cerda S, Farraye F
Gastrointest Endosc
. 2006 Mar;
63(4):707-8, discussion 708.
PMID: 16564882
No abstract available.
2.
Koomen J, Li D, Xiao L, Liu T, Coombes K, Abbruzzese J, et al.
J Proteome Res
. 2005 Jun;
4(3):972-81.
PMID: 15952745
The low molecular weight plasma proteome and its biological relevance are not well defined; therefore, experiments were conducted to directly sequence and identify peptides observed in plasma and serum protein...
3.
Yao M, Zhou W, Sangha S, Albert A, Chang A, Liu T, et al.
Clin Cancer Res
. 2005 Mar;
11(4):1618-28.
PMID: 15746067
Purpose: To determine whether the nonselective and relatively inexpensive nonsteroidal anti-inflammatory drug ibuprofen would be effective in inhibiting colorectal cancer and might improve mortality in a mouse model. Experimental Design:...
4.
Zou T, Selaru F, Xu Y, Shustova V, Yin J, Mori Y, et al.
Oncogene
. 2002 Jul;
21(31):4855-62.
PMID: 12101425
In order to discover global gene expression patterns characterizing subgroups of colon cancer, microarrays were hybridized to labeled RNAs obtained from seventeen colonic specimens (nine carcinomas and eight normal samples)....
5.
Xu Y, Selaru F, Yin J, Zou T, Shustova V, Mori Y, et al.
Cancer Res
. 2002 Jun;
62(12):3493-7.
PMID: 12067993
cDNAmicroarrays, combined with bioinformatics analyses, are becomingincreasingly used in current medical research. Existing analytic methods,particularly those that are unsupervised, often have difficulty recognizing subtle differences among predefined subgroups. In contrast,...
6.
Selaru F, Xu Y, Yin J, Zou T, Liu T, Mori Y, et al.
Gastroenterology
. 2002 Mar;
122(3):606-13.
PMID: 11874992
Background & Aims: There is a subtle distinction between sporadic colorectal adenomas and cancers (SAC) and inflammatory bowel disease (IBD)-associated dysplasias and cancers. However, this distinction is clinically important because...